Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNU Capsule in Refractory Functional Dyspepsia
NCT03844100Phase 2Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Nov 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CnU in functional dyspepsia (FD), sponsored by Gangnam Severance Hospital. Primary endpoint: Improvement of symptoms at 12 weeks. Started Nov 2019; status: completed.
02
Drugs
CnU
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03844100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844100.